No Image Provided

Bioniq

VC Funding

Series A

Healthcare & Biotech Published 9 February 2022

Summary

In a significant market movement during February 2022, Bioniq was the subject of a vc funding. The transaction achieved a gross valuation of £11,052,252. Leading the round was OKS Group, Medsi Group.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

OKS Group

Lead Investor / Acquirer

Medsi Group

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series A prioritised

VC Funding

Luna Pet Healthcare

£700,000

May 2026

VC Funding

Koalaa

£941,985

Feb 2024

VC Funding

Newcells Biotech

£2,350,000

Feb 2024

VC Funding

TalkLife

Undisclosed

Feb 2024

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.